BIOXYTRAN, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
BIOXYTRAN, INC. (BIXT) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 15.38 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2026-04-15
- BIOXYTRAN, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2023-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- BIOXYTRAN, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2023-09-30 was 0.00 shares.
- BIOXYTRAN, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2022-12-31 was 228.03K shares.
- BIOXYTRAN, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2022-09-30 was 0.00 shares.
- BIOXYTRAN, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2025 was 15.38M shares.
- BIOXYTRAN, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2023 was 800.00K shares, a 62.58% increase from fiscal 2022.
- BIOXYTRAN, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2022 was 492.06K shares.
- BIOXYTRAN, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2020 was 405.33K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | 15.38M shares 10-K · filed 2026-04-15 | ||||||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-03 | 0.00 shares derived: sum of 2 quarters · filed 2025-04-03 | 800.00K shares 10-K · filed 2025-04-03 | ||||
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 800.00K shares 10-Q · filed 2023-11-03 | |||||
| 2023-06-30 | 800.00K shares 10-Q · filed 2023-07-31 | ||||||
| 2022-12-31 | 228.03K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-01-13 | 228.03K shares derived: sum of 2 quarters · filed 2025-01-13 | 228.03K shares derived: sum of 3 quarters · filed 2025-01-13 | 492.06K shares 10-K/A · filed 2025-01-13 | 492.03K shares 10-K · filed 2023-03-31 | ||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-03 | 264.03K shares 10-Q · filed 2023-11-03 | 492.03K shares 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | 264.03K shares 10-Q · filed 2023-07-31 | 264.06K shares 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | 264.03K shares 10-Q · filed 2023-05-12 | ||||||
| 2020-12-31 | 405.33K shares 10-K · filed 2022-04-11 |